Contrasting functions of IgG and IgE antimalarial antibodies in uncomplicated and severe Plasmodium falciparum malaria

American Journal of Tropical Medicine and Hygiene

Volumn 62, Issue 3, 2000, Pages 373-377

  Perlmann, P ^a   Perlmann, H ^a   Looareesuwan, S ^a   Krudsood, S ^a   Kano, S ^a   Matsumoto, Y ^a   Brittenham, G ^a   Troye Blomberg, M ^a   Aikawa, M ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; PARASITEMIA; PATHOGENESIS; PLASMODIUM FALCIPARUM;

EID: 0033774979     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.62.373     Document Type: Article

References (41)

1. Plasmodium-specific immunoglobulin E in sera from an area of holoendemic malaria
2. IgE elevation and IgE antimalarial antibodies in Plasmodium falciparum malaria: Association of high IgE levels with cerebral malaria
3. Immunoglobulin E elevation in Plasmodium chabaudi malaria
4. Production and activities of IgE in helminth infection
5. Nitric oxide production by human monocytes: Evidence for a role of CD23
6. Tumor necrosis factor and disease severity in children with Plasmodium falciparum malaria
7. TNF-α concentrations in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria
8. Malarial toxins and the regulation of parasite density
9. Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria
10. Severe complicated malaria
11. A comparative clinical trial of sequential treatments of severe malaria with artesunate suppository followed by mefloquine in Thailand
12. Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: Two- and three-day regimes
13. Regulation of the immune response in Plasmodium falciparum malaria II. Antigen specific proliferative responses in vitro
14. Quantitative rather than qualitative differences between monocytes with respect to IgE Fc receptor expression as studied by flow cytometry
15. Impairment of Plasmodium falciparum-specific antibody response in severe malaria
16. Classification of clinical falciparum malaria and its use for the evaluation of chemosuppression in children under six years of age in Liberia, West Africa
17. Malaria a neglected disease?
18. Immunodepression in children with malaria
19. Cutaneous delayed-type hypersensitivity responsiveness in patients during and after Plasmodium falciparum and Plasmodium vivax infections
20. Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum
21. Antibodies against malaria sporozoites in patients with acute uncomplicated malaria and patients with cerebral malaria
22. Antibody against a ring-infected erythrocyte surface antigen in cerebral and non-cerebral malaria patients
23. IgG1 and IgG2 antibody responses to Plasmodium falciparum exoantigens correlate inversely and positively, respectively, to the number of malaria attacks
24. Parasite virulence and disease patterns in Plasmodium falciparum malaria
25. Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal
26. The isotype composition and avidity of naturally acquired anti-Plasmodium falciparum antibodies: Differential patterns in clinically immune Africans and Amazonian patients
27. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection
28. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
29. Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea
30. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion invitro, but act in cooperation with monocytes
31. Gamma-globulin and acquired immunity to human malaria
32. Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria
33. Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, West Africa)
34. Atypical IgG subclass antibody responses to Plasmodium falciparum asexual stage antigens
35. IgE and TNF in malaria infection. Protection-and pathogenicity: Two sides of the same coin
36. IgE and tumor necrosis factor in malaria infection
37. Intercellular adhesion molecule-1 as an endothelial cell adhesion receptor for Plasmodium falciparum
38. Immunoblot characterization of IgG, IgM and IgE antibodies elicited during the course of fatal and non-fatal infections of Plasmodium berghei in DBA/2 and Balb/c mice
39. Immunoglobulin complex deposits in Plasmodium falciparum-infected placentas from Malawi and Papua New Guinea
40. Elevated plasma levels of IgE in Plasmodium falciparum-primed individuals reflect an increased ratio of IL-4 to interferon-gamma (IFN-γ)-producing cells
41. Interleukin 4 causes isotype switching to IgE in T-cell stimulated clonal B-cell cultures